These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10208564)

  • 1. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.
    Laws SM; Taddei K; Martins G; Paton A; Fisher C; Clarnette R; Hallmayer J; Brooks WS; Gandy SE; Martins RN
    Neuroreport; 1999 Mar; 10(4):879-82. PubMed ID: 10208564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
    Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
    J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
    Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
    Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
    Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?
    Lambert JC; Mann D; Richard F; Tian J; Shi J; Thaker U; Merrot S; Harris J; Frigard B; Iwatsubo T; Lendon C; Amouyel P
    J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):928-33. PubMed ID: 15965197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.
    Ezquerra M; Blesa R; Tolosa E; Ballesta F; Oliva R
    Neurosci Lett; 1998 Jan; 240(2):107-9. PubMed ID: 9486483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations.
    Corbo RM; Gambina G; Ruggeri M; Scacchi R
    Dement Geriatr Cogn Disord; 2006; 22(1):67-72. PubMed ID: 16699281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease.
    Yamagata K; Urakami K; Ikeda K; Ji Y; Adachi Y; Arai H; Sasaki H; Sato K; Nakashima K
    Dement Geriatr Cogn Disord; 2001; 12(2):57-62. PubMed ID: 11173875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
    Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.
    Nacmias B; Tedde A; Latorraca S; Piacentini S; Bracco L; Amaducci L; Guarnieri BM; Petruzzi C; Ortenzi L; Sorbi S
    Ann Neurol; 1996 Oct; 40(4):678-80. PubMed ID: 8871590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
    Wang JC; Kwon JM; Shah P; Morris JC; Goate A
    Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.
    Lilius L; Froelich Fabre S; Basun H; Forsell C; Axelman K; Mattila K; Andreadis A; Viitanen M; Winblad B; Fratiglioni L; Lannfelt L
    Neurosci Lett; 1999 Dec; 277(1):29-32. PubMed ID: 10643890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.